HAGGIAG, SHALOM
 Distribuzione geografica
Continente #
NA - Nord America 180
EU - Europa 137
AS - Asia 36
AF - Africa 2
SA - Sud America 2
Totale 357
Nazione #
US - Stati Uniti d'America 176
IT - Italia 62
GR - Grecia 15
DE - Germania 12
GB - Regno Unito 10
IE - Irlanda 8
CN - Cina 7
IN - India 7
IR - Iran 7
JP - Giappone 7
DK - Danimarca 6
ES - Italia 5
CA - Canada 4
FR - Francia 4
NL - Olanda 4
QA - Qatar 3
TR - Turchia 3
CZ - Repubblica Ceca 2
HU - Ungheria 2
BE - Belgio 1
BF - Burkina Faso 1
BR - Brasile 1
CH - Svizzera 1
CL - Cile 1
FI - Finlandia 1
HR - Croazia 1
LT - Lituania 1
PH - Filippine 1
PT - Portogallo 1
TW - Taiwan 1
UA - Ucraina 1
ZA - Sudafrica 1
Totale 357
Città #
Rome 30
Houston 16
Santa Cruz 16
Ann Arbor 12
Ashburn 12
Buffalo 11
Fairfield 11
Dublin 7
Woodbridge 7
Menlo Park 6
Seattle 6
Copenhagen 5
Beijing 4
Forest Grove 4
New York 4
Wilmington 4
Cambridge 3
Chicago 3
Doha 3
Las Vegas 3
Paris 3
Tokyo 3
Vigo 3
Bengaluru 2
Bromley 2
Dearborn 2
Hangzhou 2
Istanbul 2
Los Angeles 2
Madrid 2
San Diego 2
Stanford 2
Wageningen 2
Alsip 1
Andover 1
Anzio 1
Baltar 1
Beverly Hills 1
Boardman 1
Brescia 1
Casoria 1
Chennai 1
Chieri 1
Chiyoda-ku 1
Columbus 1
Council Bluffs 1
Dachau 1
Debrecen 1
Des Moines 1
Dordrecht 1
Duncan 1
Fleming Island 1
Frankfurt am Main 1
Goldach 1
Helsinki 1
High Point 1
Ilk 1
Jena 1
Kalaheo 1
La Spezia 1
Leipzig 1
Leonberg 1
Leuven 1
Madison 1
Magdeburg 1
Mangalore 1
Milpitas 1
Muizenberg 1
Mumbai 1
Munich 1
Napoli 1
Omaha 1
Onna 1
Ottawa 1
Patti 1
Phoenix 1
Reggio Nell'emilia 1
Riva 1
Rochester 1
Rockville 1
Sacrofano 1
Samsun 1
Saskatoon 1
Shanghai 1
South Bend 1
Suita 1
Tampa 1
Toronto 1
Valby 1
Valparaiso 1
Waltham 1
Totale 254
Nome #
Real-world effectiveness of natalizumab and fingolimod compared with self-injectable drugs in non-responders and in treatment-naïve patients with multiple sclerosis, file e3835316-20bb-15e8-e053-a505fe0a3de9 242
Humoral- and T-Cell-Specific Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients With MS Using Different Disease-Modifying Therapies, file e383532d-a31e-15e8-e053-a505fe0a3de9 74
Fingolimod vs dimethyl fumarate in multiple sclerosis. a real-world propensity score-matched study, file e383531b-0292-15e8-e053-a505fe0a3de9 32
Early-onset optic neuropathy as initial clinical presentation in SPG7, file e383531a-2b14-15e8-e053-a505fe0a3de9 16
Abortion induces reactivation of inflammation in relapsing-remitting multiple sclerosis, file e383531c-29d9-15e8-e053-a505fe0a3de9 4
Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis. An Italian, Multicenter, Real-World Study, file e383531b-9b9f-15e8-e053-a505fe0a3de9 3
‘Posture second’ strategy predicts disability progression in multiple sclerosis, file e3835328-24af-15e8-e053-a505fe0a3de9 3
Exit strategies for "needle fatigue" in multiple sclerosis: a propensity score-matched comparison study, file e383532d-431d-15e8-e053-a505fe0a3de9 3
Early-onset optic neuropathy as initial clinical presentation in SPG7, file e3835312-3328-15e8-e053-a505fe0a3de9 2
Real-world effectiveness of natalizumab and fingolimod compared with self-injectable drugs in non-responders and in treatment-naïve patients with multiple sclerosis, file e3835321-4bf6-15e8-e053-a505fe0a3de9 1
Premorbid functional reserve modulates the effect of rehabilitation in multiple sclerosis, file e383532c-0d3c-15e8-e053-a505fe0a3de9 1
Monoallelic KIF1A‑related disorders: a multicenter cross sectional study and systematic literature review, file e383532e-b8a9-15e8-e053-a505fe0a3de9 1
Totale 382
Categoria #
all - tutte 467
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 467


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201942 1111 143 63 5052
2019/202043 1132 54 53 6553
2020/202173 8362 52 54 861311
2021/2022141 73418 239 245 4112310
2022/202381 452517 86 103 3000
Totale 382